Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | USNA | AVTX | ||
| Company | Akebia Therapeutics | Usana Health Sciences Inc | Avalo Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 1.3800 | 20.54 | 16.21 | ||
| High | 1.3900 | 21.99 | 16.36 | ||
| Low | 1.3300 | 20.45 | 15.63 | ||
| Latest | 1.3400 | 21.60 | 15.64 | ||
| Change | -0.0400 | +1.12 | -0.55 | ||
| % Change | -2.90% | +5.47% | -3.40% | ||
| Volume | 2,478,800 | 175,700 | 226,600 | ||
| 20-Day Average Volume | 3,113,195 | 138,540 | 315,645 | ||
| Previous Close | 1.3800 | 20.48 | 16.19 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5500 | 19.97 | 17.60 | ||
| 20-Day Raw Stochastic | 7.14% | 87.21% | 8.98% | ||
| 20-Day Relative Strength | 32.69 | 59.71 | 43.05 | ||
| Weighted Alpha | -51.06 | -30.50 | +145.12 | ||
| Today's Opinion | 100% Sell | 40% Sell | 56% Buy | ||
| Previous Opinion | 100% Sell | 48% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Sell | 80% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.07% since 01/08/26 | +7.95% since 01/08/26 | -8.59% since 01/08/26 | ||
| Low | 1.3100 on 01/13/26 | 19.65 on 01/09/26 | 15.63 on 01/15/26 | ||
| High | 1.5400 on 01/09/26 | 21.99 on 01/15/26 | 17.47 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -16.77% since 12/15/25 | +6.30% since 12/15/25 | -11.64% since 12/15/25 | ||
| Low | 1.3100 on 01/13/26 | 18.94 on 01/05/26 | 15.19 on 01/05/26 | ||
| High | 1.7300 on 12/22/25 | 21.99 on 01/15/26 | 20.20 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | -54.58% since 10/15/25 | +5.31% since 10/15/25 | +12.52% since 10/15/25 | ||
| Low | 1.3100 on 01/13/26 | 18.48 on 11/19/25 | 13.60 on 10/17/25 | ||
| High | 3.2000 on 10/28/25 | 21.99 on 01/15/26 | 20.72 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | -65.46% since 07/15/25 | -31.03% since 07/15/25 | +225.83% since 07/15/25 | ||
| Low | 1.3100 on 01/13/26 | 18.48 on 11/19/25 | 4.81 on 07/17/25 | ||
| High | 4.0400 on 07/22/25 | 38.32 on 07/23/25 | 20.72 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 366,205 | 374,395 | 299,726 | ||
| Shares Outstanding, K | 265,366 | 18,281 | 18,513 | ||
| Annual Sales | 160,180,000 | 854,500,000 | 440,000 | ||
| Annual Net Income | -69,410,000 | 42,030,000 | -35,130,000 | ||
| Last Quarter Sales | 58,770,000 | 213,670,000 | 0 | ||
| Last Quarter Net Income | 540,000 | -6,520,000 | -30,630,000 | ||
| 60-Month Beta | 0.35 | 0.65 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/10/25 | -0.15 on 10/22/25 | -2.19 on 11/06/25 | ||
| Latest Earnings Date | 03/12/26 | 02/17/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.36 | 0.00 | ||